Publication | Open Access

Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Response

Surgical OncologyBreast OncologyMedicineAdjuvant ChemotherapyPathologyBreast CancerTriple-negative Breast CancerCancer TreatmentOncologyImproved Survival Compared